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"Al! depends on keeping the eye steadily fixed on the facts of
nature, and so receiving their images as they are. For God
forbid that we should give out a dream ofour own imagination







Bacteriophages - "bacteria eaters" - are tiny viruses that
make their living by infecting bacteria. The late Max Delbriick,
one of the pioneers of molecular biology, described bacterio-
phage research as "a fine playground for serious children who
ask ambitious questions."
In 1952 Norton Zinder, a graduate student at the University
of Wisconsin, reported in his doctoral dissertation that bac-
teriophages can pick up genes from one bacterium and deposit
them in another. Molecular biology was in its infancy. The
identification of DNA as the genetic material had been reported
only eight years earlier and was still being debated. Watson
and Crick had yet to build a model of the double helix structure
of DNA. And the universality of the genetic code to all living
beings was years from being established. "A lot of people didn't
even believe bacteria had genes," Dr. Zinder says.
His faculty advisor and collaborator in this research was a
young assistant professor named Joshua Lederberg (later presi-
dent of The Rockefeller University). "My thesis examination,"
Dr. Zinder recalls, "was essentially a conversation between Josh
and me. The four other professors in attendance, while expert
in the traditional bacteriology of the day, were frankly baffled
by what we were saying."
They were talking about a process called transduction, na-
ture's model for what we now know as recombinant DNA
technology. The development of modern molecular genetic re-






















B. Plasmid, now removedfrom
bacterium, into which a
segment offoreign DNA
will be introduced.
C. The plasmid is cut open
with specific restriction
enzymes.







of the natural mechanisms ofgenetic transfer and recombination
in the cells of microorganisms.
Genes encode the instructions that control the activities of
living beings: the synthesis of proteins, which comprise the
major structural and regulatory molecules in cells, and the
creation of new beings. Recombinant DNA technology has
provided a tool for research on the structure and function of
genes more powerful than any that has ever before been avail-
able. Not just for the study of the genes of microbes, but of
those of every species of living creature including man. Today,
biologists are pinpointing the genes responsible for diseases.
They are mapping the human genome - our genetic package.
A new biotechnology based on recombinant DNA science is
beginning to mass-produce critically important biological
molecules for medicine, agriculture, and industry.
Dr. Zinder, now John D. Rockefeller Professor of The Rocke-
feller Univ.ersity and head of the University's genetics laboratory,
has an ingenious way of illustrating how DNA technology
works. He uses strips of Velcro.
He attaches two strips of:equal size down their length to
represent the double strands of a segment of DNA. Sticking
their ends together to form a ring, he makes a plasmid. Plasmids
are small, circular extra molecules of DNA that float around
in bacteria outside the chromosomes. In recombinant DNA
technology, plasmids are often used as transducing agents. In
his demonstration, Dr. Zinder opens the plasmid ring and
attaches its ends to the ends of the strands of a particular genes
DNA and closes the enlarged ring. "If I now put this into a
bacterium," he explains, 'TIl have a little factory churning out
identical copies-clones-of the gene~nd of the genes product."
In an article entitled "Frorn'Genetics to Genetic Engineer-
ing," written thirty years after the discovery of transduction,
Dr. Zinder stated: "We have had two revolutions in molecular
genetics in my lifetime. Both were dependent on the same two
components - a knowledge of DNA structure and a sophisti-
cated ability to move genes about. The first depended on natural
processes and hence was limited. The second transcends species
barriers and is without limit." Both began for Dr. Zinder in
unsettling circumstances.
OUT OF THE FRYING PAN
Some years ago, Dr. Zinder was invited to speak at the bicen-
tennial celebration of Columbia University's College of Physi-
cians and Surgeons. He began his lecture by thanking the school
for rejecting his application for medical studies in 1947 because
otherwise "I might not have had the pleasure of addressing
you today." Telling the story he remarks with relish, "you wait
a lifetime for an opening line like that."
"Not that I ever planned to practice medicine," he adds. "I
always wanted to do research, but I had this idea that to be
able to do it I had to have a medical degree." Bright and
energetic, a voracious reader, and a fierce stickball competitor,
he breezed through the Bronx High School ofScie'nce and raced
through pre-med studies at Columbia College, cheerleading at
football games and taking twenty credits a semester. He was
graduated, at the age of eighteen, with a "gentleman's B" that
failed to compete with the flood of medical school applications
from returning World War II veterans.
During the following year, he worked as a psychiatric aide
at a hospital, and on the advice of his college genetics professor,
Francis Ryan, he applied to the University of Wisconsin for
graduate studies with Joshua Lederberg, who had preceded
him at Columbia but whom he had never met. Months passed.
"I was on a fishing trip when I got a telegram from my folks
saying I was expected in Madison in two days," Dr. Zinder
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From Dr. Zinder's original
1948 experiments to iso/ate
mutant bacteria using penicillin.
Top, the ratio ofnormal
bacteria (black dots) to mutants
(white dots) is one hundred to
one. After the addition of
penicillin, the ratio is reversed,
be/ow.
was furious. In any event, maybe it was the stimulus of the
tension, but Josh got this brilliant idea - to use penicillin.
Penicillin kills only growing cells. Mutants don't grow unless
you give them certain kinds of supplements in the medium.
I designed some experiments and they worked. Zappo! We had
mutants falling out of the sky."
Mating could now be sought in other species. To be sure
that the new cells were rhe product of mating and not just cell
division they mixed strains that differed from one another in
more than one trait. "We expected to find offspring with a
mixture of traits from both parents," Dr. Zinder says. "Instead,
they all resembled one parent. At first we thought we had
stumbled on an instance of transformation. We tested it with
an enzyme that normally kills naked DNA. Nothing changed.
Knowing that, bacteriophages became suspect."
Like all viruses, bacteriophages are simply little packages of
genes wrapped up in a protein coat. They survive and reproduce
by intruding their genetic instructions into the DNA of the
cells they invade, often subverting the instructions the cells
need for their own survival. As with other viruses, -some bac-
teriophages are extremely lethal. "Infected cells can disappear
in front of your eyes," Dr. Zinder says. Others will lie low for
a while, only occasionally bursting out and moving on to other
cells.
As the two young researchers determined, bacteriophages,
protected by their protein coats from the destructive enzyme
in the medium mix, were indeed infecting the bacteria. And
when they left a cell they were taking with them some of the
cell's DNA, which then recombined with the DNA in the cells
that they next infected: transduction.
Despite the perplexity of his thesis examiners, Dr. Zinder
got his Ph.D. Looking back, he reflects: "It's hard now to
remember an era when people didn't comprehend what we now
so easily understand as genetics - the genetics of everything.
My examiners were good biochemists and microbiologists but
they didn't think genetically. To them genetics had to do only
with fruitflies and corn. It was a stroke of incredible insight
on the part of the department chairman, R.A. Brink, himself
a corn geneticist, to have hired Josh."
Dr. Zinder's degree was not, however, in genetics but in
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encounter a broiling basement laboratory and "a twenty-three-
year-old wunderkindwho knew everything and assumed I did, too."
The first discovery of a natural mechanism of genetic recom-
bination, called transformation, also provided the first evidence
that genes were made of DNA. It was reported in 1944 by
Oswald Avery, Colin Macleod, and Maclyn McCarty, bacteri-
ologists at the hospital of what was then The Rockefeller Insti-
tute for Medical Research. They were trying to understand how
heat-killed pneumonia bacteria could affect living ones, a
phenomenon that had been observed some years before by the
British pathologist Fred Griffith. What they found was that
the live bacteria possessed the ability to pick up free DNA
released from the dead ones.
When Joshua Lederberg read Avery's paper he postponed
(and never resumed) his medical studies to pursue its implica-
tions. Two years later, working with geneticist Edward Tatum,
he discovered a second type of DNA recombination in bacteria
- conjugation, a kind of primitive sexual mating. Normally,
bacteria reproduce simply by dividing in half. In rare instances,
as Lederberg and Tatum found, two bacteria will attach and
form a connecting bridge through which one of the bacteria
will pass a chromosomal strand to the other. This discovery
provided a whole new technique for genetic study.
When organisms mate, their offspring inherit different com-
binations and distributions of genes. One of the classic ways
geneticists exploit this is by mating a normal organism with
a mutant, an organism with an alteration in the normal gene
arrangement. By comparing offSpring it becomes possible to
get a handle on what genes are responsible for the synthesis of
what proteins by seeing what proteins are lacking or altered
when genes are lacking or altered.
At Wisconsin, Dr. Lederberg was trying to expand his con-
jugation findings to other species of bacteria. Dr. Zinder's job
was to make the mutants. Biologists make mutants by exposing
organisms to environmental or chemical insults. "Today," Dr.
Zinder says, "making mutants is a pleasure. In those days it
was an ordeal. Not to speak of the fact that I had barely ever
handled a pipette and had never had a microbiology. course in
my life."
A month later there were no mutants. "Josh was upset. I
medical microbiology. "Josh and I had decided that that way
at the very worst I might wind up doing scool cultures in a
hospital, but I'd get a job. At that time, a job in genetics
usually had to await the demise of a university's sole genetics
professor. "
As it turned out, he wound up at Rockefeller, eventually
associated with Rollin Hotchkiss (now professor emeritus), who
was expanding Avery's findings on transformation. Dr. Zinder
continued to refine transduction and to begin intensive studies
of the genetic structure of bacteribphages, work that continues
in his laboratory to this day.
Dr. Zinder offers a wry footnote to the Wisconsin era of his
career. He remembers that in 1951 the physicist Leo Szilard,
with "characteristic brilliance and prescience," told him to
patent transduction.
INTO THE FIRE
Recombinant DNA technology across species came to fruition
when it became possible to cut DNA at specific sites using
chemical scissors called restrictions enzymes. "We knew what
we were looking for," Dr. Zinder says. "We had the theory. All
we needed to do was find the enzymes."
They were found, in 1970, by Johns Hopkins biologist
Daniel Nathans. "Dan's lab was working on one enzyme," says
Dr. Zinder. "My lab was working on another. His enzyme
recognized a specific site and cut it. Mine recognized a specific
site and cut somewhere else. Why? I don't know why. Because
that's how God made it."
A decade earlier, when Dr. Nathans was at Rockefeller, he
and Dr. Zinder collaborated on experiments that helped to
explain the mechanisms of the genetic code, the system whereby
the instructions encoded in DNA are translated into the synthe-
sis of proteins. The message, written in a four-letter chemical
alphabet, is copied from DNA to RNA, another nucleic acid.
Messenger RNA relays it to the cell's protein-making plants,
where each "word" of the message instructs the cell to make
an amino acid, the small molecules that, strung together, build
proteins.
The first protein synthesized in a test tube was made using
a bacteriophage as the messenger. Phage f2, as it is called, is
one of a very few viruses, and the only such creatures in nature,
whose genes are made of RNA rather than DNA. Discovered
in Dr. Zinder's laboratory, phage f2 provided, he says, "a
powerful check" on the fidelity of the in vitro system being
used to develop the genetic code.
In 1973 the first genetic chimera was made by means of
recombinant DNA science. But the thrill of achievement was
soon tempered by concern. An experiment had been proposed
in which a tumor-causing virus was to be cloned in a human
intestinal bacterium. Some scientists began to ask whether
such experiments posed a danger. Was it possible that harmful
and uncontrollable recombinants might inadvertently get loose
from the laboratory? In 1974 a committee of the National
Academy of Sciences called for a temporary moratorium on
certain kinds of experiments. Dr. Zinder was among the com-
mittee's eleven members. In March of the following year, he
joined an international group of one hundred and forty molec-
ular biologists at a meeting in Asilomar, California. Working
around the clock for four days, they hammered out a set of
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Professor Peter- Model, co-leader-
ofthe genetics laboratory, whose
bacter-iophage research is helping
to explain how genes express
themselves, control one another,
and cooper-ate to create new
organisms. Currently, Dr.
Model is concentrating on
questions ofhow virus proteins
are inser-ted into the membranes
ofhost cells, what makes them
stay ther-e, and how new viroses
are assembled at the host cell's
surface.
Postdoctoral Fellow Benedicte
Michel from the InstitutJacques
Monod, in France, whose
research focuses on the regulation
ofDNA synthesis in
bacter-iophage.
research guidelines, which were adopted by the National Insti-
tutes of Health.
But the genie was out of the bottle, as James Watson later
put it. The Recombinant DNA War erupted in headlines in
the press and in heated public debate. Pressure mounted for
restricting legislation. Dr. Zinder round himself on the front
lines of the battle, an angry David armed with a Velcro slingshot
and a temperament inclined to what a student of his diplomat-
ically terms "animated discussion."
"The thing that mobilized us," says Dr. Zinder, "was local
communities getting into the act. We would have accepted
regulation from Washington. What we were afraid of, and what
we came very close to having imposed on us, were laws in New
York saying one thing and laws in California saying another.
You can't do science that way. You can't compete. You can't
collaborate. What was most discouraging was that the people
writing the local legislation didn't know the first thing about
the science they were proposing to regulate."
The discussion continued - with senators, with congress-
men, with governors, with legislative aides, with reporters,
with environmentalists, with public action groups, with other
scientists - rising to a crescendo in 1976 and 1977. When
the dust settled there was no legislation.
"There are still skirmishes," says Dr. Zinder, such as the
recent disputes about modified bacteria being used to prevent
plants from freezing. But the concerns that scientists had first
expressed were eventually resolved through research that pro-
vided detailed understanding and showed recombinant organ-
isms to be no more dangerous than the components of which
they were made.
In 1982 Dr. Zinder, along with biologists Paul Berg of









Institutes of Health, received the first award for Scientific Free-
dom and Responsibility given by the American Association for
the Advancement ofScience. It was presented to them for their
leadership during the DNA debate.
The recombinant DNA controversy was not Dr. Zinder's first
experience with science and public policy. In 1973, during the
Nixon administration's "War on Cancer," he was asked by the
National Cancer Board to be chairman of a committee to review
the Special Virus Cancer Program of the National Cancer Insti-
tute. The report the committee submitted early the following
year was highly critical. Not of the need for viral cancer research,
but of the manner in which the program was being administered
largely through contracts for specifically targeted goals.
"Contract research can do some things very well," Dr. Zinder
says. "It's fine for developing applications of research. What it's
not good for is basic research, when the nature of the problem
hasn't even begun to be fathomed. How can you contract some-
one to come up with an idea, a discovery, in X number of
months or years?" The Zinder Report, as it was called, resulted
in a reapportionment of research funds with a greatly lessened
emphasis on contracts.
Dr. Zinder is again spending time in WashingtOn. A few
years ago, he was asked to join a National Research Council
committee to advise on the disposal of the country's obsolete
chemical warfare weapons. "We have a huge stockpile of these
weapons," he says, "all made before 1969 and in various stages
of disintegration. How do you get rid of them? Do you dump
them in the ocean? Do you burn them up? Do you blow them
up? Do you neutralize them chemically? Do you send them to
the moon?"
Over a two-year period, members of the committee inspected
all the American stOckpiles in the United States and abroad
B.A.
C. Filamentous phages
currently under study in
Dr. Zinder's laboratory.
Because this kind of
bacteriophage is a filament
it can come in many sizes
and thus can carry foreign
DNA.
B. David Russell, who
presented his Ph.D.
dissertation this winter on
a biochemical mechanism
that acts to prevent DNA
replication in
microorganisms.
A. The human intestinal
bacteria E. coli. The
hair/ike projection, or
pilus (magnified in the
inset), is covered with
RNA bacteriophage in
which the genetic material
is made ofRNA instead of
DNA. Thefirst RNA
phage was discovered in
Dr. Zinder's laboratory
and was an important tool




Drs. Model and Zinder in front
ofa nucleic acid synthesizer, or
"gene machine, " in which pieces
ofgenetic material are made.
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and pur together their report. Their suggestion is combustion,
which they have deemed to be far less hazardous and cumber-
some than any other method. "The main problem," Dr. Zinder
explains, "is that a lot of these weapons are configured in
bombs and rockets. You have to crack them open or disassemble
them by remote control in such a way that they don't explode.
It's a very slow, tedious process."
Now chairman of the National Academy ofScience's oversight
committee for the project, Dr. Zinder will continue to shuttle
to Washington over the next several years. "It takes me away
from the lab, which I don't like, bur I feel an obligation to see
it through." Beginning this summer, he will be serving the
National Academy of Sciences in another role. An .academy
member since 1969, he has been elected to its ruling council.
BACK TO BASICS
Starting with Joshua Lederberg, Dr. Zinder has been, he says,
"most fortunate" in his associates. At Rockefeller, he "grew up"
in Rollin Hotchkiss's laboratOry, much as Peter Model, a col-
league of more than twenty years, grew up in his, and whose
work has provided significant insights into the structure and
assembly of the lab's current favorite phage.
Most of the other members of the laboratory are students.
"Over the years, my lab has been largely run with students,"
Dr. Zinder says, "They're smart, they're fun, and they say what
they think." He smiles. "They remind me of me. I don't give
them orders. We talk about· science. I tell them what interests
me. They tell me what interests them. Then I let them do
what they want to do. They have to be taught a lot technically,
but that's the 'how' part, not the 'what.'" "Norton works
through suggestion," says Joseph Heitman, a current student.
"Sometimes it's very subtle. Sometimes it shifts the whole way
you're thinking."
Sometimes it's not so subtle. David Russell, another student,
wanted to pursue an idea about a mechanism he thought affected
DNA replication. Dr. Zinder didn't think it did. Russell took
his chances and went ahead with the research. "Norton went
over the work with a fine-tooth comb," he says. The paper was
published last year in the prestigious journal Cell, with Dr.
Zinder's name appended after Russell's in the traditional senior
scientist approval slot.
Throughout his career, Dr. Zinder's interest has remained
steadfastly focused on basic inquiries into the structure and
function of genes. He concentrates on bacteriophages because
they are easier to understand and to handle than higher forms.
The phages currently under study in his laboratory have, at
most, ten genes. The human genome contains a hundred
thousand or more. Many of the fundamental ideas about how
genes operate, which have made it possible for scientists to
dare to approach higher forms, were achieved through such
research on microorganisms.
"What basic scientists do," says Dr. Zinder, "is try to under-
stand how living things work. I think it's an acceptable argu-
ment that knowledge of itself has intrinsic value. If you want
to push me as to what 'good' it does, is it going to cure cancer
or something, I can only answer that I don't know. I don't know
if it will help us cure cancer, but I can absolutely guarantee
you that without it we never will."
What Dr. Zinder's research has provided for science to date
is three bacteriophages, each a tool that has contributed to
important findings. First there was P22, the phage that unco-
vered transduction of bacterial genes. The second was RNA
phage f2, which helped unravel the details of protein biosyn-
thesis and the genetic code. The current favorite alluded to
earlier is the filamentous phage fl, which can provide single
strands of any piece of DNA for use in probing and sequencing
genes. In the company of a new generation of "serious children"
he continues to ask ambitious questions. D
